Sarah Le Meur

Title: The Innovative Contributions of Sarah Le Meur

Introduction

Sarah Le Meur is a prominent inventor based in Brussels, Belgium. She has made significant contributions to the field of medicine through her innovative work. Her research focuses on developing selective inhibitors of PI3 kinase enzymes, which are crucial in treating various medical conditions.

Latest Patents

Sarah Le Meur holds a patent for "Crystalline forms of seletalisib." This patent, designated as Form B and Form F, describes crystalline forms that are selective inhibitors of PI3 kinase enzymes, particularly the human PBKδ isoform. These inhibitors are beneficial in treating inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive, or ophthalmic conditions. She has 1 patent to her name.

Career Highlights

Sarah is currently employed at UCB Biopharma Sprl, where she continues her research and development efforts. Her work has been instrumental in advancing medical treatments and improving patient outcomes.

Collaborations

Some of her notable coworkers include Vincent Adolphe, Carol Cool, and Georges Assaf. Their collaborative efforts contribute to the innovative environment at UCB Biopharma Sprl.

Conclusion

Sarah Le Meur's contributions to the field of medicine through her patent and collaborative work highlight her role as an influential inventor. Her research continues to pave the way for advancements in medical treatments.